Silicone versus Nonsilicone Gel Dressings: A Controlled Trial

Oliveira, Gisele Viana de; Nunes, Tarcizo Afonso; Magna, Luís Alberto; Cintra, Maria Letícia; Kitten, Gregory T.; Zarpellon, Sergio Luis; Amaral, Cassio Meneses Raposo Do

doi:10.1046/j.1524-4725.2001.00345.x

Cited by 73 publications

(81 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The use of silicone dressings is recommended as a safe, non-invasive, simple, and effective method of prophylaxis [18,[22][23][24]. The use of silicone dressings substantially improves the flexibility of old scars as compared to the scars untreated with plasters [1].…”

Section: Discussionmentioning

confidence: 99%

“…Most researchers believe that silicone dressings reduce the activity of the capillaries, reduce congestion, and reduce the production of fibroblasts and collagen, causing flattening of the scar. Randomised studies have shown that the use of silicone dressings is effective in improving the colour, size, and hardness of the scar [24]. Treatment of a patient who has a problem with a scar should be selected on the basis of the scar assessment.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Pressotherapy of a postoperative scar with the application of non-sterile silicone dressings in a 56-year-old woman treated for breast cancer in the Holycross Cancer Centre in Kielce

Macek¹,

Terek-Derszniak²,

Lipińska³

et al. 2015

View full text Add to dashboard Cite

Scarring is a natural process of wound healing. In some cases, however, there is formation of hypertrophic scars and keloids that are the result of collagen decomposition and synthesis. A disturbed scarring process causes functional, aesthetic, and psychological disorders in the patient. Silicone dressings in the form of plasters or gel are used in the treatment of hypertrophic scars and keloids. A case of pressotherapy of a postoperative scar with the use of non-sterile silicone dressings in a 56-year-old patient treated for breast cancer is described herein. The use of a 2-month pressotherapy of the scar resulted in an improvement in all the assessed parameters. Pressotherapy of the postoperative scar in the patient after mastectomy proved to be an effective and promising method. However, the methods of the scar assessment before and after treatment need objectivity.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Pressotherapy of a postoperative scar with the application of non-sterile silicone dressings in a 56-year-old woman treated for breast cancer in the Holycross Cancer Centre in Kielce

Macek¹,

Terek-Derszniak²,

Lipińska³

et al. 2015

View full text Add to dashboard Cite

show abstract

“…28 However, the blinding and the randomization techniques were not reported, and the patients were followed up for only 12 weeks. De Oliveira et al 51 performed a randomized controlled trial in 26 patients who had hypertrophic and keloid scars, and used a combination of silicone gel sheeting, nonsilicone gel sheeting and an untreated control. Their study did not demonstrate any significance in scar size or symptoms with any of the treatments; however, both KD and hypertrophic scars were combined in the analysis, and follow-up measurements occurred after < 6 months.…”

Section: Intralesional Steroid Injectionsmentioning

confidence: 99%

Strategic management of keloid disease in ethnic skin: a structured approach supported by the emerging literature

Uddin

Bayat

2013

Br J Dermatol

View full text Add to dashboard Cite

SummaryKeloid disease (KD) is a common, benign, dermal fibroproliferative growth of unknown aetiology. Lesions tend to grow over time; they often recur following therapy and do not regress spontaneously. KD causes considerable discomfort due to pain, pruritus and inflammation, and a significant psychosocial impact with reduced quality of life. It is unique to humans and occurrence is higher in individuals with dark, pigmented, ethnic skin. There is a strong familial heritability, with a high ethnic predisposition in individuals of African, Asian and Hispanic descent. High recurrence rates and unknown resolution rates present a major problem for both the patient and clinician. Many treatment modalities exist; however, there is no single advocated therapy. Therefore, the aim of this review was to explore the most current literature regarding the range of treatment options for KD and to offer a structured approach in the management of KD, based on evidence and experience, to aid clinicians in their current practice. A focused history involving careful evaluation of the patient's symptoms, signs, quality of life and psychosocial well-being should direct targeted therapy, complemented with regular follow-up and re-evaluation. Many treatment modalities, such as intralesional steroid injection, silicone gel application, cryotherapy, lasers, 5-fluorouracil and, relatively recently, photodynamic therapy, are currently being used in clinical practice for the management of KD. Combination therapies have also been shown to be beneficial. However, there is a lack of robust, randomized, level-one, evidence-controlled trials evaluating these treatment options. Management of KD in ethnic pigmented skin remains a clinical challenge. Thus, a strategic approach with structured assessment, targeted therapy and focus on prevention of recurrence is highly recommended. Quality evidence is essential in order to tailor treatment effectively for the ethnic patient presenting with KD.What's already known about this topic?• Keloid disease (KD) is a common, benign, fibroproliferative tumour of unknown origin.• With high recurrence rates, treatment of KD remains a challenge for both the patient and clinician.• With lack of level-one evidence, there is no single advocated therapy.What does this study add?• A structured strategic approach for management of KD by utilizing a focused history, targeted therapy and regular follow-up of the patient.• Patients' symptoms, signs, quality of life and psychosocial well-being should be carefully evaluated and managed.

show abstract

“…4,5,[48][49][50] When used prophylactically on surgical incisions, it can prevent the development of pathologic scars. [51][52][53] Silicone gel sheets were the mainstay of siliconebased treatments until relatively recently. Unfortunately, these sheets could be difficult to use, particularly in large areas, in areas near or over joints, and in areas with high degrees of contour variability, such as the face.…”

Section: Mechanical Therapymentioning

confidence: 99%

Emerging Therapies for Scar Prevention

Block

Gosain

2015

Advances in Wound Care

View full text Add to dashboard Cite

Significance: There are *12 million traumatic lacerations treated in the United States emergency rooms each year, 250 million surgical incisions created worldwide every year, and 11 million burns severe enough to warrant medical treatment worldwide. In the United States, over $20 billion dollars per year are spent on the treatment and management of scars. Recent Advances: Investigations into the management of scar therapies over the last decade have advanced our understanding related to the care of cutaneous scars. Scar treatment methods are presented including topical, intralesional, and mechanical therapies in addition to cryotherapy, radiotherapy, and laser therapy. Critical Issues: Current treatment options for scars have significant limitations. This review presents the current and emerging therapies available for scar management and the scientific evidence for scar management is discussed. Future Directions: Based upon our new understanding of scar formation, innovative scar therapies are being developed. Additional research on the basic science of scar formation will lead to additional advances and novel therapies for the treatment of cutaneous scars.

show abstract

Silicone versus Nonsilicone Gel Dressings: A Controlled Trial

Abstract: Silicone and nonsilicone gel dressings are equally effective in the treatment of keloids and hypertrophic scars.

Cited by 73 publications

References 37 publications

Pressotherapy of a postoperative scar with the application of non-sterile silicone dressings in a 56-year-old woman treated for breast cancer in the Holycross Cancer Centre in Kielce

Pressotherapy of a postoperative scar with the application of non-sterile silicone dressings in a 56-year-old woman treated for breast cancer in the Holycross Cancer Centre in Kielce

Strategic management of keloid disease in ethnic skin: a structured approach supported by the emerging literature

Emerging Therapies for Scar Prevention

Contact Info

Product

Resources

About